Investors | Eli Lilly and CompanyLilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide ...24 Maymore_vert
Indianapolis Business JournalLilly to invest another $5.3B in Lebanon site to meet overwhelming demand for Mounjaro, Zepbound – Indianapolis ...24 MayJohn RussellBy John Russellmore_vert
Business Facilities MagazineLilly To Invest $5.3B More In Indiana Pharmaceutical Manufacturing24 Maymore_vert
The Wall Street JournalEli Lilly to Spend $5.3 Billion to Boost Output of Mounjaro and Zepbound24 MayPeter LoftusBy Peter Loftusmore_vert
ForbesMounjaro Shortage: Eli Lilly Invests $5.3 Billion For Production24 MayTy RoushBy Ty Roushmore_vert
MyWabashValley.comEli Lilly adds $5.3 billion investment in Lebanon LEAP district24 MayDavid GayBy David Gaymore_vert
ReutersLilly invests further $5.3 bln in new Indiana site as obesity drug demand soars24 MayPatrick WingroveBy Patrick Wingrovemore_vert
QuartzEli Lilly will invest $9 billion in manufacturing Zepbound, Mounjaro24 MayBruce GilBy Bruce Gilmore_vert
Country 103.9 WRBIGov. Joins Lilly to Announce Additional $5.3 Billion Investment – WRBI Radio28 MayTom SnapeBy Tom Snapemore_vert
The Center SquareEli Lilly investment in Lebanon up to $9B24 MaySteve BittenbenderBy Steve Bittenbendermore_vert
FiercePharmaLilly designates additional $5.3B for huge API plant in Indiana24 MayKevin DunleavyBy Kevin Dunleavymore_vert